Back-Translation

Back-translation is a quality assurance technique where a completed translation is independently retranslated back into the source language by a second translator who has not seen the original text. The back-translated version is then compared against the original to identify potential errors, misinterpretations, or meaning shifts.

This method is most commonly used in clinical research, pharmaceutical documentation, and regulated industries where translation accuracy has direct safety implications. The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recommends back-translation as part of the linguistic validation process for patient-reported outcome measures and clinical trial questionnaires.

However, back-translation has significant limitations as a standalone quality measure. It can identify obvious errors and meaning shifts, but it cannot assess naturalness, cultural appropriateness, or readability in the target language. A translation can back-translate perfectly while sounding unnatural or confusing to native speakers of the target language.

Back-translation can also produce false positives — flagging differences that are actually legitimate alternative translations rather than errors. This can lead to unnecessary revision cycles and increased costs without improving the quality of the final translation.

LEXIGO recommends back-translation selectively, primarily for clinical and regulatory content where it is a required step. For most other content types, we advocate for more effective quality assurance methods including in-country review, comparative review by a second linguist, and automated quality checks — approaches that assess the translation on its own merits rather than through the distorting lens of retranslation.

Understanding the strengths and limitations of back-translation helps organisations make smarter quality assurance decisions. Over-reliance on back-translation can create a false sense of security while consuming budget that could be better spent on more effective review methods.

For clinical and pharmaceutical clients, back-translation remains an important compliance step. For everyone else, knowing when it adds genuine value versus when alternative QA methods are more effective can save significant time and money while actually improving translation quality.